Qiagen N.V. (QGEN): Price and Financial Metrics

QGEN POWR Grades

• QGEN scores best on the Quality dimension, with a Quality rank ahead of 91.27% of US stocks.
• The strongest trend for QGEN is in Growth, which has been heading down over the past 177 days.
• QGEN's current lowest rank is in the Momentum metric (where it is better than 6.37% of US stocks).

QGEN Stock Summary

• With a market capitalization of $9,326,346,240, QIAGEN NV has a greater market value than 84.1% of US stocks.
• With a one year PEG ratio of 451.88, QIAGEN NV is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.71% of US stocks.
• The volatility of QIAGEN NV's share price is greater than that of just 6.96% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to QGEN, based on their financial statements, market capitalization, and price volatility, are FOXF, HOLX, FCEL, LOGI, and IRIX.
• QGEN's SEC filings can be seen here. And to visit QIAGEN NV's official web site, go to www.qiagen.com.

QGEN Valuation Summary

• In comparison to the median Healthcare stock, QGEN's EV/EBIT ratio is 98.75% higher, now standing at 15.9.
• QGEN's price/sales ratio has moved up 1.7 over the prior 243 months.

Below are key valuation metrics over time for QGEN.

QGEN Growth Metrics

Its year over year net income to common stockholders growth rate is now at 20.09%.
• Its 5 year revenue growth rate is now at 17.41%.
• Its 3 year revenue growth rate is now at 53.48%.

Over the past 15 months, QGEN's revenue has gone up $195,591,000.

The table below shows QGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	2,261.046	733.338	514.298
2022-03-31	2,312.842	717.784	538.688
2022-03-31	2,312.842	717.374	538.688
2021-12-31	2,251.657	639.001	512.599
2021-12-31	2,251.657	NA	512.599
2021-09-30	2,240.493	710.255	596.098

QGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• QGEN has a Quality Grade of B, ranking ahead of 79.35% of graded US stocks.
• QGEN's asset turnover comes in at 0.375 -- ranking 125th of 682 Pharmaceutical Products stocks.
• ALNY, TXMD, and CASI are the stocks whose asset turnover ratios are most correlated with QGEN.

The table below shows QGEN's key quality metrics over time.